Immunogenic control of tumours and tumour cells
US10617748B2 · kind B2 · utility
3Cited by
24References
26Claims
0Family size
Assignees
Inventor
Key dates
| Filing date | Jan 5, 2015 |
| Grant date | Apr 14, 2020 |
| Priority date | — |
| Expiry date | Jan 5, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/33
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of immunogenic peptides comprising a T-cell epitope derived from a tumor-associated antigen and a redox motif such as C-(X)2-[CST] or [CST]-(X)2-C in the treatment of a tumor or in the treatment or prevention of a tumor relapse, and in the manufacture of medicaments therefore.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.